Results 61 to 70 of about 135,134 (317)

Onasemnogene Abeparvovec in Type I Spinal Muscular Atrophy: 24‐Month Follow‐Up From the Italian Registry

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane   +43 more
wiley   +1 more source

Minnesota Shade Tree Advocate newsletter, volume 2, issue 4, winter 1999

open access: yes, 1999
Minnesota Shade Tree Advisory Committee. (1999). Minnesota Shade Tree Advocate newsletter, volume 2, issue 4, winter 1999.
Minnesota Shade Tree Advisory Committee
core  

Quantifying the Impact of Ocrelizumab on Paramagnetic Rim Lesions in Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Paramagnetic rim lesions (PRLs) are a subset of chronic active multiple sclerosis (MS) lesions marked by iron‐laden microglia and macrophages. Ocrelizumab, a monoclonal antibody targeting CD20+ B cells, suppresses acute MS activity, but its effect on PRLs remains unclear. In a longitudinal study of 29 ocrelizumab‐treated patients with at least
Kimberly H. Markowitz   +9 more
wiley   +1 more source

Minnesota Shade Tree Advocate newsletter, volume 4, issue 2, spring 2001

open access: yes, 2001
Minnesota Shade Tree Advisory Committee. (2001). Minnesota Shade Tree Advocate newsletter, volume 4, issue 2, spring 2001.
Minnesota Shade Tree Advisory Committee
core  

Tenth annual report of the Shade Tree Commission

open access: yes, 1913
A yearly series of reports from the Newark Shade Tree Commission which covers planting, care, and inventory of shade trees in the city of Newark, New Jersey.

core   +1 more source

Cracking the Code: Genotype–Phenotype Correlation Models in Sarcoglycanopathies

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Sarcoglycanopathies are among the most severe limb‐girdle muscular dystrophies (LGMD), though milder presentations have been described. These diseases are primarily caused by missense variants, but the limited predictability of their effect on protein maturation, complex formation, and transport has hindered reliable genotype ...
Leonela Luce   +72 more
wiley   +1 more source

Minnesota Shade Tree Advocate newsletter, volume 7, issue 4, fall 2005

open access: yes, 2005
Minnesota Shade Tree Advisory Committee. (2005). Minnesota Shade Tree Advocate newsletter, volume 7, issue 4, fall 2005.
Minnesota Shade Tree Advisory Committee
core  

A Depolarizing Leak in Sodium Bicarbonate Cotransporter NBCe1 Causes Brain Edema

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives SLC4A4 encodes electrogenic sodium bicarbonate cotransporter NBCe1, prominently expressed in kidney and brain. Recessive loss‐of‐function variants in SLC4A4 cause proximal renal tubular acidosis, no brain edema. In the brain, NBCe1 is expressed by astrocytes, where it regulates pH and mediates astrocyte volume changes.
Quinty Bisseling   +16 more
wiley   +1 more source

Qualidade fisiológica de sementes de pitangueira submetidas a diferentes procedimentos de secagem e substratos - Parte 2 Physiological quality of surinam cherry seeds submitted to different procedures of drying and substrates - Part 2

open access: yesRevista Brasileira de Engenharia Agrícola e Ambiental, 2010
Conduziu-se este trabalho com o objetivo de determinar o procedimento de secagem e substratos ideais para avaliar a visibilidade e o vigor das sementes e crescimento inicial das plântulas de pitangueira (Eugenia uniflora L.).
Lúcia H. de M. Sena   +4 more
doaj   +1 more source

Minnesota Shade Tree Advocate newsletter, volume 2, issue 3, summer 1999

open access: yes, 1999
Minnesota Shade Tree Advisory Committee. (1999). Minnesota Shade Tree Advocate newsletter, volume 2, issue 3, summer 1999.
Minnesota Shade Tree Advisory Committee
core  

Home - About - Disclaimer - Privacy